Genentech, Inc.

13 Archived Projects

Title Investigator Start
End
Phase II Double Blinded, Placebo-Controlled, Efficacy and Safety Evaluation of Allergen Immunotherapy Co-Administered with Omalizumab, an Anti-IgE mAb Bluestone
A Pilot Study of FOLFOX in Combination with Bevacizumab in Patients with Advanced Neuroendocrine Tumors Bergsland
Clinical Research Fellowship for Nisha Acharya Acharya
Task Order Number #2 - Development
Effect of Ranibizumab on Refractory Macular Edema in Uveitis Phase I/II Acharya
Characterizing the Rheological Properties of Cystic Fibrosis Sputum and the Effects of Mucoactive Agents.
Phase 1b, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of MEGF0444A, A Humanized 1gG1 Antibody in Combination with Bevacizumab with or without Paclitaxel in Patients with Locally Advanced or Metastatic Solid Tumors
Identification of Viruses in an Asthma Cohort Chiu
YV25718: A phase IIIb parallel group, open label study of pegylated interferon alfa-2a monotherapy (PEG-IFN, Ro 25-8310) compared to untreated control in children with HBeAg positive chronic hepatitis B Rosenthal
UCSF-Genentech Asthma Collaboration Task Order Burchard
Study for Sample Acquisition for Patients Diagnosed with S. aureus Bacteremia Chambers
Harvesting of S. Mansoni schistosoma eggs McKerrow
A Phase III Study Of Lebrikizumab In Patients With Uncontrolled Asthma Who Are On Inhaled Corticosteriods And A Second Controller Medication Nahid